Laboratory Corp. of America Holdings Share Price Today: Live Updates & Key Insights

Laboratory Corp. of America Holdings share price today is $263, up -0.41%. The stock opened at $263.7 against the previous close of $264.09, with an intraday high of $265.14 and low of $261.24.

Laboratory Corp. of America Holdings Share Price Chart

Laboratory Corp. of America Holdings

us-stock
To Invest in {{usstockname}}
us-stock

Laboratory Corp. of America Holdings Share Price Performance

$263 -0.0041(-0.41%) LH at 23 Mar 2026 01:58 PM Diagnostics & Research
Lowest Today 261.24
Highest Today 265.14
Today’s Open 263.7
Prev. Close 264.09
52 Week High 292.20
52 Week Low 207.15
Day’s Range: Low 261.24 High 265.14
52-Week Range: Low 207.15 High 292.20
1 day return -
1 Week return -1.39
1 month return -7.78
3 month return +3.13
6 month return -5.68
1 year return +11.26
3 year return +41.26
5 year return +26.21
10 year return -

Laboratory Corp. of America Holdings Institutional Holdings

Vanguard Group Inc 11.95

BlackRock Inc 9.86

Victory Capital Management Inc. 6.50

State Street Corp 4.65

Vanguard Total Stock Mkt Idx Inv 3.16

Allspring Global Investments Holdings, LLC 2.68

JPMorgan Chase & Co 2.61

Geode Capital Management, LLC 2.59

Vanguard 500 Index Investor 2.56

Select Equity Group LP 2.56

Wellington Management Company LLP 2.38

Boston Partners Global Investors, Inc 2.32

Vanguard Mid Cap Index Institutional 2.18

Bank of New York Mellon Corp 2.15

Allspring Special Mid Cap Value Inst 1.85

Morgan Stanley - Brokerage Accounts 1.83

Allspring Mid Value SMA 1.82

Allspring Special US Mid Cap Value Eq 1.82

FMR Inc 1.63

Dimensional Fund Advisors, Inc. 1.58

Amvescap Plc. 1.58

Diamond Hill Capital Management Inc 1.53

Victory Sycamore Established Value R 1.44

Victory Pioneer A 1.37

Pioneer US Large Core Equity 1.34

AllianceBernstein L.P. 1.34

iShares Core S&P 500 ETF 1.28

Fidelity 500 Index 1.28

Northern Trust Corp 1.25

Veritas Investment Partners (UK) Ltd. 1.25

NORGES BANK 1.20

State Street® SPDR® S&P 500® ETF 1.19

Amundi Fds US Pioneer A USD C 0.94

Vanguard Value Index Inv 0.93

Vanguard Health Care Inv 0.84

Hartford Dividend and Growth Y 0.81

Invesco S&P 500® Equal Weight ETF 0.79

State Street®HlthCrSelSectSPDR®ETF 0.75

Fidelity Low-Priced Stock 0.66

Vanguard Mid-Cap Value ETF 0.62

Laboratory Corp. of America Holdings Market Status

Strong Buy: 13

Buy: 3

Hold: 4

Sell: 0

Strong Sell: 0

Laboratory Corp. of America Holdings Fundamentals

Market Cap 21802.70 M

PB Ratio 2.5141

PE Ratio 25.1194

Enterprise Value 27664.90 M

Total Assets 18392.70 M

Volume 818880

Laboratory Corp. of America Holdings Company Financials

Annual Revenue FY25:13951700000 13951.7M, FY24:13008900000 13008.9M, FY23:15070900000 15070.9M, FY22:14876800000 14876.8M, FY21:16120900000 16120.9M

Annual Profit FY25:3732500000 3732.5M, FY24:3624400000 3624.4M, FY23:4017800000 4017.8M, FY22:4385100000 4385.1M, FY21:5624300000 5624.3M

Annual Net worth FY25:876500000 876.5M, FY24:746000000 746.0M, FY23:661200000 661.2M, FY22:1279100000 1279.1M, FY21:2377300000 2377.3M

Quarterly Revenue Q4/2025:3515800000 3515.8M, Q3/2025:3563500000 3563.5M, Q2/2025:3527300000 3527.3M, Q1/2025:3345100000 3345.1M, Q4/2024:3329400000 3329.4M

Quarterly Profit Q4/2025:920600000 920.6M, Q3/2025:1025100000 1025.1M, Q2/2025:1046200000 1046.2M, Q1/2025:948000000 948.0M, Q4/2024:896300000 896.3M

Quarterly Net worth Q4/2025:164700000 164.7M, Q3/2025:261100000 261.1M, Q2/2025:237900000 237.9M, Q1/2025:212800000 212.8M, Q4/2024:143400000 143.4M

About Laboratory Corp. of America Holdings & investment objective

Company Information Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Organisation Diagnostics & Research

Employees 61770

Industry Diagnostics & Research

CEO Mr. Adam H. Schechter

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Laboratory Corp. of America Holdings FAQs

What is the share price of Laboratory Corp. of America Holdings today?

The current share price of Laboratory Corp. of America Holdings is $263.

Can I buy Laboratory Corp. of America Holdings shares in India?

Yes, Indian investors can buy Laboratory Corp. of America Holdings shares by opening an international trading and demat account with Motilal Oswal.

How to buy Laboratory Corp. of America Holdings shares in India?

You can easily invest in Laboratory Corp. of America Holdings shares from India by:

Can I buy fractional shares of Laboratory Corp. of America Holdings?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Laboratory Corp. of America Holdings?

Laboratory Corp. of America Holdings has a market cap of $21802.70 M.

In which sector does Laboratory Corp. of America Holdings belong?

Laboratory Corp. of America Holdings operates in the Diagnostics & Research sector.

What documents are required to invest in Laboratory Corp. of America Holdings stocks?

To invest, you typically need:

What is the PE and PB ratio of Laboratory Corp. of America Holdings?

The PE ratio of Laboratory Corp. of America Holdings is 25.12 and the PB ratio is 2.51.